- Bristol Myers Squibb (Cambridge, MA)
- …The Oncology Thematic Research Center at BMS is a key research and early development engine, responsible for the discovery and development of novel ... outcome. We are a fully integrated drug discovery through translational and early clinical development organization which exploits state-of-the-art in vitro, in… more
- Bristol Myers Squibb (Cambridge, MA)
- …The Oncology Thematic Research Center at BMS is a key research and early development engine, responsible for the discovery and development of novel ... outcome. We are a fully integrated drug discovery through translational and early clinical development organization which exploits state-of-the-art in vitro, in… more
- Dana-Farber Cancer Institute (Boston, MA)
- … detection tests and implementation strategies in clinical and population settings + Development and testing of biomarkers of early cancer and precancerous ... **Postdoctoral Fellowship in Cancer Screening, Early Detection, and Cancer Interception** **Dana-Farber Cancer Institute, Department of Medical Oncology ,… more
- Bristol Myers Squibb (Cambridge, MA)
- …The Oncology Thematic Research Center at BMS is a key research and early development engine, responsible for the discovery and development of novel ... outcome. We are a fully integrated drug discovery through translational and early clinical development organization which exploits state-of-the-art in vitro, in… more
- Astellas Pharma (Cambridge, MA)
- …Conceive and manage oncology -focused drug discovery programs from early concept through preclinical development . Collaborate across multi-disciplinary teams ... II, Discovery Targeted Therapy** opportunity at their Astellas Life Science Center (ALSC) in Cambridge, MA. **Purpose:** The Discovery Targeted Therapy Research… more
- Sumitomo Pharma (Boston, MA)
- …the US (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene therapies and CNS. With ... several marketed products and a diverse pipeline of early - to late-stage investigational assets, we aim to accelerate discovery, research, and development to… more